author-photo

Wolfgang Hiddemann

Ludwig Maximilian University of Munich
German Cancer Research Center

551

Papers

13951

Citations

Citation Trend

Filter By

Papers (551) Sort By

JournalConferenceOthers

The Addition of Rituximab to Cyclophosphamide, Doxorubicine, Vincristine and Prednisone (CHOP) Prolongs Overall Survival in Previously Untreated Mantle Cell Lymphoma: A Long Term Pooled Trials Analysis

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Long-term survival of patients with mantle cell lymphoma after autologous haematopoietic stem-cell transplantation in first remission: a post-hoc analysis of an open-label, multicentre, randomised, phase 3 trial

2021 The Lancet Haematology
Show All
- Source
- Cite
- Save
Citations (1)
Characteristics and outcome of patients with low-/intermediate-risk acute promyelocytic leukemia treated with arsenic trioxide - an international collaborative study.

2021 Haematologica
Show All
- Source
- Cite
- Save
Citations (2)
Multi-Dimensional Analysis of Adult Acute Myeloid Leukemia (AML) Landscape Cross-Continents Reveals Age Associated Trends in Mutations and Outcomes

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Rituximab Maintenance Versus Observation After Immunochemotherapy (R-CHOP, R-MCP, and R-FCM) in Untreated Follicular Lymphoma Patients: A Randomized Trial of the Ostdeutsche Studiengruppe Hämatologie und Onkologie and the German Low-Grade Lymphoma Study Group.

2021
Show All
- Source
- Cite
- Save
Citations (0)
An EZH2 Gene Expression Signature Is Predictive of Differential Efficacy of Chemotherapy Irrespective of EZH2 Mutation Status in Patients with Follicular Lymphoma Treated within the Gallium Trial

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Validation of POD24 As a Robust Early Clinical Endpoint of Poor Survival in FL from 5,225 Patients on 13 Clinical Trials.

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
A Clinically Applicable Gene Expression based Score predicts Resistance to Induction Treatment in Acute Myeloid Leukemia.

2021 Blood Advances
Show All
- Source
- Cite
- Save
Citations (0)
High Prevalence of CHF and Diabetes in AML Long-Term Survivors - a Patient Forever?

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Single-nucleotide Fcγ receptor polymorphisms do not impact obinutuzumab/rituximab outcome in patients with lymphoma

2021 Blood Advances
Show All
- Source
- Cite
- Save
Citations (0)

© Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.

沪ICP备18028330号